Applying regulatory science to neonates: launch of the International Neonatal Consortium (INC)

The International Neonatal Consortium is a coalition of industry, academia, patient representatives, the Food and Drug Administration, the European Medicines Agency, other governmental agencies, foundations, professional organizations, and the Critical Path Institute (C-Path) that will focus on accelerating the development of therapeutics for the neonatal population. At this workshop, participants will prioritise projects and initiate collaborations to develop safe and effective treatments for neonates. Registration open until 11 May 2015.